Heparin-induced thrombocytopenia: discrepancy between the presence of IgG cross-reacting in vitro with fraxiparine and its successful clinical use.
Luzzatto
G
G
Cordiano
I
I
Patrassi
G
G
Fabris
F
F
D003429:Cross Reactions; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D017762:Nadroparin / Q000276:immunology / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
D007074:Immunoglobulin G; D017762:Nadroparin; D006493:Heparin